EUROIMMUN Logo
Find
X

What are you looking for?

Filter for products in our complete portfolio

Product finder

Worldwide
X
EUROIMMUN worldwide

This website provides an overview of the business activities and products of EUROIMMUN AG worldwide. Not all products are registered and approved in all countries or regions. Please contact your country representative for product availability and information

EUROIMMUN branches

Choose your country

Europe

North America

South & Central America

Asia

Middle East & Africa

EUROIMMUN Logo

Press releases and articles

Unlock new potential – 23 new assays for the UNIQO 160

The state-of-the-art UNIQO 160 is EUROIMMUN’s all-in-one system reducing manual working steps, increasing productivity and ensuring maximum diagnostic precision. Full automation of indirect ...

Test systems backed up by extensive scientific studies [...]

Abnormally elevated blood pressure (hypertension, HT) is a major cause of premature death and a challenge worldwide, with an estimated number of >1 billion adults aged 30–79 years having hypertension, ...

EUROLabPolaris Support Platform – Personalised support for your IFA evaluation

Diagnostics using indirect immunofluorescence tests (IFA) cover a wide range of indications and therefore have long been the gold standard in the laboratory. However, despite the many diagnostic ...

Line blot for myositis shows high agreement with biopsy

A multiparameter EUROLINE blot for detection of myositis-related autoantibodies showed a high agreement with muscle biopsy results in patients with idiopathic inflammatory myopathies (IIM), suggesting ...

Role of Epstein-Barr virus in multiple sclerosis

The frequency of intrathecal antibody production to Epstein-Barr virus (EBV) in multiple sclerosis (MS) patients is surprisingly low compared to that of other microbial agents. This was shown in a ...

Revvity’s EUROIMMUN Receives CE Mark for Novel Measles Antibody Detection Assay

Press release, March 3rd 2025

Revvity, Inc. (NYSE: RVTY), today announced the launch of EUROIMMUN’s CE-marked Anti-Measles Virus ELISA 2.0 (IgG) to support the diagnosis of a measles virus infection ...

SARS-CoV-2 vaccine safety in an autoimmunity-prone population

A new study has shown that mRNA vaccines against SARS-CoV-2 do not induce short-term worsening of autoimmunity in patients with autoimmune liver diseases (AILD). The collaborative study between ...

Serum uromodulin may indicate acute kidney injury in COVID-19 patients

Serum uromodulin (sUmod) represents a promising biomarker for acute kidney injury (AKI) in COVID-19 patients, as reported in a published collaborative study between EUROIMMUN, St Georg Hospital ...

Another piece of the puzzle in rheumatological diagnostics

Systemic autoimmune rheumatic diseases encompass a wide range of different inflammatory joint, tissue and vascular diseases, such as rheumatoid arthritis, systemic lupus erythematosus and systemic ...

Two companies, one goal

Panadea and EUROIMMUN are two companies with one common important goal: The development, production and distribution of test systems for the detection of the pathogens causing such emerging diseases, ...

Page 1 of 10.

Back to top